| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.73B | 55.64B | 51.40B | 69.46B | 59.93B | 45.80B |
| Gross Profit | 10.00B | 10.10B | 10.22B | 11.24B | 9.68B | 8.20B |
| EBITDA | 4.61B | 4.74B | 5.06B | 6.06B | 4.33B | 2.92B |
| Net Income | 3.17B | 3.05B | 2.99B | 3.69B | 2.37B | 1.73B |
Balance Sheet | ||||||
| Total Assets | 26.32B | 25.54B | 23.87B | 24.89B | 23.52B | 21.63B |
| Cash, Cash Equivalents and Short-Term Investments | 13.60B | 14.08B | 14.50B | 15.37B | 12.65B | 10.65B |
| Total Debt | 159.00M | 383.00M | 442.00M | 1.98B | 2.96B | 4.00B |
| Total Liabilities | 6.43B | 6.06B | 6.02B | 8.28B | 9.38B | 9.40B |
| Stockholders Equity | 19.42B | 19.05B | 17.51B | 16.32B | 13.93B | 12.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.15B | 3.13B | 5.26B | 3.77B | 1.47B |
| Operating Cash Flow | 0.00 | 3.23B | 3.17B | 5.32B | 3.77B | 1.52B |
| Investing Cash Flow | 0.00 | -1.88B | -201.00M | 167.00M | 396.00M | -300.59M |
| Financing Cash Flow | 0.00 | -2.11B | -4.06B | -2.81B | -2.20B | -1.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥52.46B | 13.60 | ― | 3.98% | 10.52% | 7.14% | |
73 Outperform | ¥82.10B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
68 Neutral | ¥81.62B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
67 Neutral | ¥309.70B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥315.66B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥321.68B | 20.24 | ― | 1.28% | 8.11% | -9.27% |